Coeptis Therapeutics Inc.
COEP | NASDAQ
$10.99
-$1.03 (-8.57%)
At close: Jul 2, 2026, 3:59 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -18.16M | -12.72M | -12.12M | -13.51M | -12.6M | -11.3M | -10.88M | -11.62M | -16.05M | -16.13M | -21M | -20.19M | -19.57M | -26.26M | -37.57M | -35.85M | -36.15M | -28.15M | -10.92M | -26.98M | -21.03M | -19.23M |
Depreciation & Amortization | 1.77M | 1.23M | 1.22M | 1.18M | 1.15M | 1.09M | 1.05M | 1.04M | 1.01M | 1.01M | 1M | 1M | 1M | 1M | 1M | 1.2M | 947.26K | 697.28K | 447.41K | 1.21K | 848 | 481 |
Stock-Based Compensation | 7.25M | 1.82M | 1M | 1.09M | 1.19M | 1.61M | 1.1M | 805.35K | 821.76K | 323.49K | 348.99K | 348.99K | 235.69K | 122.39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 15.67K | -631.72K | -1.07M | -1.1M | -808.13K | -105.01K | 167.79K | 272.76K | 359.33K | 359.86K | 202.26K | -474.61K | -514.95K | -530.31K | -507.19K | -2.89M | -4M | -4.01M | -3.74M | -734.53K | 322.87K | 289.43K |
Other Non-Cash Items | 5.08M | 2.43M | 2.75M | 4.5M | 3.34M | 1.92M | 2.21M | 2.05M | 7.21M | 6.77M | 11.72M | 13.56M | 12.97M | 21.07M | 33.25M | 30.61M | 31.16M | 24.35M | 7.33M | 24.13M | 19.33M | 17.68M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.09M | -807.81K | -807.81K | -807.81K | 286.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 12.73K | -756.49K | -1.46M | -1.61M | -1.17M | -432.89K | -134.39K | 817.25K | 1.14M | 1.38M | 1.49M | -312.41K | -388.18K | -532.65K | -550.34K | -2.71M | -5.32M | -5.35M | -5.01M | -2M | 510.96K | 477.52K |
Operating Cash Flow | -4.04M | -8M | -8.6M | -8.35M | -8.09M | -7.11M | -6.65M | -6.91M | -6.97M | -7.46M | -7.24M | -6.39M | -5.47M | -4.6M | -3.88M | -7.2M | -9.81M | -8.9M | -8.59M | -4.85M | -1.2M | -1.07M |
Capital Expenditures | -6 | -6 | -3 | -3 | n/a | 1 | 1 | -1 | -1 | -2 | -2 | n/a | -1 | 0 | 0 | 0 | -4.05M | -4.05M | -4.05M | -4.05M | 7 | 2 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 333.34K | 333.34K | 333.34K | 333.34K | n/a | n/a | n/a | n/a | -75.75M | -75.75M | -75.75M |
Sales Maturities Of Investments | n/a | 506.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -43.03M | -43.03M | -43.03M | -43.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 85.41K | n/a | 100K | 100K | 100K | n/a | -100K | 250K | -100K | n/a | n/a | -350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 591.52K | n/a | 100K | 100K | 100K | n/a | -100K | 250K | -100K | n/a | -42.69M | -43.04M | -42.69M | -42.69M | -1.75M | -5.8M | -5.8M | -5.8M | -79.8M | -75.75M | -75.75M |
Debt Repayment | n/a | n/a | 771.25K | 707.78K | 707.78K | 907.78K | 1.2M | 1.06M | 337.5K | 487.5K | -575K | -2.97M | -2.29M | -2.64M | -2.89M | -1.92M | 2.88M | 1.95M | 2.07M | 3.52M | -1.23M | -297.58K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -247.17K | -247.17K | -247.17K | -247.17K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 20.56M | 5.69M | 5.19M | 5.19M | 75.4K | 400 | n/a | 200K | 250K | 200K | 200K | -141.44K | 8.38M | 8.76M | 8.87M | 8.96M | 1.74M | 1.35M | 945.54K | 996.44K | -298.06K | -298.06K |
Financial Cash Flow | 23.21M | 8.35M | 13.74M | 12.02M | 8.43M | 10.25M | 5.71M | 6.73M | 5.03M | 6.48M | 4.92M | 433.68K | 6.68M | 4.36M | 5.49M | 16.44M | 19.01M | 18.55M | 19.91M | 88.77M | 80.16M | 79.56M |
Net Cash Flow | 13.5M | 942.82K | 5.14M | 3.77M | 441.65K | 3.24M | -936.25K | -274.06K | -1.69M | -1.08M | -2.32M | -5.96M | -4.2M | -5.42M | -3.57M | 1.61M | 2.58M | 2.54M | 4.2M | 3.51M | 2.62M | 2.74M |
Free Cash Flow | -4.04M | -8M | -8.6M | -8.35M | -8.09M | -7.11M | -6.65M | -6.91M | -6.97M | -7.46M | -7.24M | -6.39M | -5.47M | -4.6M | -3.88M | -7.2M | -13.87M | -12.96M | -12.65M | -8.9M | -1.2M | -1.07M |
Adj. Free Cash Flow | -11.29M | -9.82M | -9.61M | -9.44M | -9.28M | -8.72M | -7.75M | -7.71M | -7.79M | -7.78M | -7.59M | -6.74M | -5.7M | -4.72M | -3.88M | -7.2M | -13.87M | -12.96M | -12.65M | -8.9M | -1.2M | -1.07M |
Maintenance CapEx | -3 | -3 | n/a | n/a | n/a | 1 | 1 | -1 | -1 | -2 | -2 | n/a | -1 | 0 | 0 | 0 | -4.05M | -4.05M | -4.05M | -4.05M | 7 | 2 |
Growth CapEx | -3 | -3 | -3 | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -4.04M | -8M | -8.6M | -8.35M | -8.09M | -7.11M | -6.65M | -6.91M | -6.97M | -7.46M | -7.24M | -6.39M | -5.47M | -4.6M | -3.88M | -7.2M | -13.87M | -12.96M | -12.65M | -8.9M | -1.31M | -1.19M |
Add to Watchlist
Select watchlists to add or remove COEP